RankingsPricing
  1. US-listed companies
  2. ALNYLAM PHARMACEUTICALS, INC.
  3. Financials
  4. Total current liabilities

ALNYLAM PHARMACEUTICALS, INC.ALNY

Market cap
$56B
P/E ratio
SummaryFinancials
Period EndTotal current liabilities (Million USD)YoY (%)
Dec 31, 20241,186+22.58%
Dec 31, 2023968+26.03%
Dec 31, 2022768+10.38%
Dec 31, 2021696+18.87%
Dec 31, 2020585+65.99%
Dec 31, 2019353+96.44%
Dec 31, 2018179+24.43%
Dec 31, 2017144+9.53%
Dec 31, 2016132+112.08%
Dec 31, 201562-34.86%
Dec 31, 201495+76.99%
Dec 31, 201354+11.42%
Dec 31, 201248-40.31%
Dec 31, 201181-20.63%
Dec 31, 2010102

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)